Clinical trial
Local, Multicentre, Observational, Non-Interventional Prospective Study of Alogliptin Benzoate in Patients With Diabetes Mellitus Type 2
NCT02756832 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Local, Multicentre, Observational, Non-Interventional Prospective Study of Alogliptin Benzoate in Patients With Diabetes Mellitus Type 2
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 20, 2016
- Completion date
- April 28, 2018
- Enrollment
- 1,409 (actual)
- Sites
- 53
Conditions
As the registry lists them; a condition with its own page is linked.